Associated Papers
Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes.
Soukupova J et al.
Plos One, 2018
29649263 (PubMed )
Supplement: pone.0195761.s003.xlsx › S3
Prohibitin mutations are uncommon in prostate cancer families linked to chromosome 17q.
White KA et al.
Prostate Cancer and Prostatic Diseases, 2006
Select a paper to view details